Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis

Rheumatology (Oxford). 2010 Aug;49(8):1607-8; author reply 1608. doi: 10.1093/rheumatology/keq115. Epub 2010 Apr 28.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Research Design
  • Scleroderma, Diffuse / drug therapy*

Substances

  • Immunosuppressive Agents
  • Mycophenolic Acid